Trial intelligence / Profile preview

Hypoxia during OGD sedation: target-controlled infusion versus intermittent propofol boluses

PACTR201708002325400Completed

Sponsor
Aga Khan University
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of propofol, sponsored by Aga Khan University. Primary endpoint: Proportion of hypoxia. Started Dec 2016; status: completed.

02

Drugs

propofol

Beyond the preview

Go deeper on PACTR201708002325400.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201708002325400.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call